Cargando…
Surgical Approaches for Implanting Xen Gel Stent without Conjunctival Dissection
The XEN Gel Stent (Allergan Inc., an Abbvie company) is an implant that lowers intraocular pressure by creating a filtration pathway from the anterior chamber to the subconjunctival space, using the same pathway as trabeculectomy. While the primary method for implantation is via ab interno approach,...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445523/ https://www.ncbi.nlm.nih.gov/pubmed/32903875 http://dx.doi.org/10.2147/OPTH.S265695 |